Papers › migraines › 5871563

A randomized placebo-controlled phase 1 safety and tolerability study of a novel human anti-MERS coronavirus polyclonal intravenous immunoglobulin produced from transchromosomic cattle

The Lancet. Infectious diseases · 01-4-2018 · 5871563 on PMC →

115 citations FWCI 20.79 Animal Virus Infections Studies Read PDF → Trend

Citation data as of 2026-04-12 (OpenAlex).

Extracted findings

This paper hasn't been extracted into the knowledge graph yet. We're working through the corpus — 5871563 is in the queue.

In the meantime: Browse migraines papers → · Ask about this topic → · Explore the graph →